Senior Manager - Formulation Development (Oral Liquid & Injectable Oncology)

Umedica Laboratories Private Limited; Navi Mumbai; On-site; INR 400,000 - 700,000; Full time

Job summary

Umedica Laboratories Private Limited in Navi Mumbai invites applications for a Sr. Manager - Formulation Development to lead oncology formulation development, including oral liquids and sterile injectables, with end-to-end responsibilities from pre-formulation to regulatory support and technology transfer.

The role demands 12-14 years of relevant experience in pharmaceutical Formulation R&D, strong leadership, and a deep understanding of cGMP, data integrity, containment for HPAPIs, and global

Qualifications

• Strong expertise in oncology formulation development and HPAPIs handling.
• Experience with pre-formulation, formulation optimization, and tech transfer.
• Knowledge of cGMP, data integrity, and regulatory expectations.

Responsibilities

• Lead formulation development for oncology products including oral liquids and sterile injectables.
• Develop QbD-based development strategies and design robust, scalable formulations.
• Oversee sterile formulation development, aseptic processing, and lyophilization cycles.
• Plan, execute, and monitor batches; support technology transfer to manufacturing.
• Collaborate with QA, Regulatory, and other functions to meet timelines.
• Mentor formulation scientists and ensure compliance with safety and containment.

Skills

Formulation development

Oncology products

Sterile injectables

HPAPIs handling

QbD

Education

M.Pharm/MS/Ph.D. (Pharmaceutics)

Job description

Department: Research & Development (R&D) - Formulation Development

Industry: Pharmaceuticals - Oncology / Generic Drug Development

Experience: 12-14 Years

Number of Positions: 01

Reporting To: Head - Formulation R&D

Job Summary:

Umedica Laboratories is seeking an experienced, technically competent, and result-oriented Sr. Manager - Formulation Development to lead the development of oncology formulations, including oral liquid and sterile injectable dosage forms, for global regulated markets. The incumbent will be responsible for end-to-end product development activities encompassing pre-formulation, formulation optimization, process development, scale-up, technology transfer, regulatory support, and cross-functional team leadership while ensuring compliance with cGMP, data integrity, EHS, and containment requirements associated with handling high-potent oncology products (HPAPIs).

Key Responsibilities:

• Lead formulation development activities for oral liquid and sterile injectable oncology products, including solutions, suspensions, emulsions (where applicable), lyophilized products, and other complex dosage forms.
• Develop product development strategies based on Quality by Design (QbD) principles, Target Product Profile (TPP), critical quality attributes (CQAs), and regulatory expectations for global markets.
• Design robust, stable, and scalable formulations with focus on stability enhancement, bioavailability improvement, compatibility, sterility assurance, and overall product performance.
• Lead development of sterile formulations, including selection of manufacturing processes such as aseptic processing, terminal sterilization (where applicable), filtration studies, lyophilization cycle development, and container closure system evaluation.
• Plan, execute, and monitor laboratory batches, optimization studies, scale-up batches, exhibit/registration batches, and support successful technology transfer to manufacturing facilities.
• Provide technical expertise in troubleshooting formulation challenges, process-related issues, sterility concerns, stability failures, and commercial manufacturing challenges.
• Review and approve formulation development reports, protocols, batch manufacturing records, scientific rationales, technical risk assessments, and development documentation.
• Lead preparation, review, and technical justification of CMC sections for regulatory submissions in regulated and semi-regulated markets, including USFDA, EMA, MHRA, and ROW markets.
• Collaborate effectively with Analytical Development, Quality Assurance, Quality Control, Regulatory Affairs, Production, Engineering, Procurement, and Project Management teams to achieve project timelines.
• Ensure compliance with cGMP, Good Documentation Practices (GDP), data integrity requirements, and strict oncology safety and containment procedures.
• Conduct risk assessments, support investigations, root cause analysis, implement CAPA, and drive continuous improvement initiatives.
• Monitor project timelines, resource planning, and deliverables to ensure successful product development and commercialization.
• Guide, mentor, and develop a team of formulation scientists and executives, fostering a culture of scientific excellence, innovation, and compliance.
• Stay updated with emerging formulation technologies, regulatory guidelines, scientific literature, and the competitive landscape in oncology and complex generic product development.

Educational Qualification:

M.Pharm/MS / Ph.D. (Pharmaceutics) or equivalent qualification from a recognized university.

• Strong expertise in development of oral liquid and sterile injectable dosage forms, particularly oncology and high-potent pharmaceutical products (HPAPIs).
• Comprehensive knowledge of formulation approaches involving solubilizers, surfactants, stabilizers, preservatives, antioxidants, buffering systems, and other critical excipients.
• In-depth understanding of sterile product development, aseptic processing, sterilization methods, lyophilization, container closure integrity, extractables & leachables, and compatibility studies.
• Hands-on experience with QbD, Design of Experiments (DoE), risk assessment tools (FMEA/Ishikawa), and pharmaceutical development lifecycle management.
• Experience in scale-up, process optimization, technology transfer, process validation support, and commercial manufacturing troubleshooting.
• Strong understanding of ICH guidelines, USFDA, EMA, and other international regulatory expectations for oncology and sterile product development.
• Ability to interpret analytical data, stability studies, dissolution/release profiles, impurity trends, degradation pathways, and product characterization data.
• Familiarity with handling requirements, containment practices, and occupational safety considerations for cytotoxic and highly potent compounds.

Preferred Candidate Profile:

• 12-15 years of relevant experience in pharmaceutical Formulation R&D, with significant hands-on experience in oncology oral liquids, sterile injectables, and/or high-potent pharmaceutical products (HPAPIs).
• Proven experience in leading formulation projects from concept to commercialization.
• Exposure to regulated market submissions (USFDA, EMA, and other global markets) will be preferred.
• Experience in managing R&D teams and driving cross-functional collaboration.